1
Verkouteren, B.J.A., Wakkee, M., Reyners, A.K.L., Nelemans, P., Aarts, M.J.B., Racz, E., Terra, J.B., Devriese, L.A., Alers, R.J., Kapiteijn, E., van Doorn, R., Bekkenk, M.W., Reinders, M.G.H.C., Mosterd, K.
Veröffentlicht in: Verkouteren , B J A , Wakkee , M , Reyners , A K L , Nelemans , P , Aarts , M J B , Racz , E , Terra , J B , Devriese , L A , Alers , R J , Kapiteijn , E , van Doorn , R , Bekkenk , M W , Reinders , M G H C & Mosterd , K 2021 , ' Eight years of experience with vismodegib for advanced and multiple basal cell carcinoma patients in the Netherlands: a retrospective cohort study ' , British Journal of Cancer , vol. 124 , no. 7 , pp. 1199-1206 . https://doi.org/10.1038/s41416-020-01220-w;
2021
Veröffentlicht in: Verkouteren , B J A , Wakkee , M , Reyners , A K L , Nelemans , P , Aarts , M J B , Racz , E , Terra , J B , Devriese , L A , Alers , R J , Kapiteijn , E , van Doorn , R , Bekkenk , M W , Reinders , M G H C & Mosterd , K 2021 , ' Eight years of experience with vismodegib for advanced and multiple basal cell carcinoma patients in the Netherlands: a retrospective cohort study ' , British Journal of Cancer , vol. 124 , no. 7 , pp. 1199-1206 . https://doi.org/10.1038/s41416-020-01220-w;
2021